GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carmat (XPAR:ALCAR) » Definitions » Capex-to-Operating-Income

Carmat (XPAR:ALCAR) Capex-to-Operating-Income : 0.00 (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Carmat Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Carmat's Capital Expenditure for the six months ended in Jun. 2024 was €-1.27 Mil. Its Operating Income for the six months ended in Jun. 2024 was €-14.64 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Carmat Capex-to-Operating-Income Historical Data

The historical data trend for Carmat's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carmat Capex-to-Operating-Income Chart

Carmat Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Carmat Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Carmat's Capex-to-Operating-Income

For the Medical Devices subindustry, Carmat's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carmat's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carmat's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Carmat's Capex-to-Operating-Income falls into.



Carmat Capex-to-Operating-Income Calculation

Carmat's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-5.026) / -40.975
=N/A

Carmat's Capex-to-Operating-Income for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.268) / -14.639
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carmat  (XPAR:ALCAR) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Carmat Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Carmat's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Carmat Business Description

Traded in Other Exchanges
Address
36, avenue de l’Europe, Immeuble l’Etendard Energy III, Velizy Villacoublay, FRA, 78140
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.

Carmat Headlines

No Headlines